Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Identify top index funds for a Roth IRA that offer tax-free growth, solid diversification, and low fees to support long-term retirement goals.
23,054 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
In 2025, holdings' 2025 review: from fintech disruptor to banking powerhouse marks a turning point from rapid scale t...
Household bills are climbing again amid a web of factors from aging infrastructure to data-center demand. This report...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
Prediction-market trading on Iran’s leadership surged as tensions flared, but unverified rumors triggered rapid price...
Geopolitical tension over Iran raises the risk of a prolonged strait hormuz closure, with analysts warning it could l...
Lockheed Martin has surged in 2026, led by a robust backlog and growing cash flow that underpin a genuine stock 2026 ...
As kontoor brands (ktb) 2025 unfolds, investors are weighing margins, brand strength, and growth channels. This artic...
Regulatory rhetoric around the Clarity Act ignites a fresh XRP debate, with Cardano founder Charles Hoskinson warning...
XRP is testing a long-running support line that has preceded every major rally since 2014, now coinciding with new ET...
Bitcoin surged past $70,000 on March 4, 2026, signaling a potential turn in a months-long selloff. As traders debate ...
JPMorgan initiates SPX Technologies with an Overweight rating and a $260 target, signalling a favorable view on data-...